Canjing Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma.
Journal: Frontiers in pharmacology
Published: April 27, 2022
Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma.
Journal: Journal of immunology research
Published: March 04, 2022
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.
Journal: Molecular therapy oncolytics
Published: October 27, 2021
Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.
Journal: Annals of translational medicine
Published: July 04, 2020
Antitumor effects of icaritin and the molecular mechanisms.
Journal: Discovery medicine
Published: June 30, 2020
Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma.
Journal: Journal of Cancer
Published: May 08, 2019
Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Journal: Investigational new drugs
Published: July 21, 2017
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 03, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026